The Human Chimeric anti-CEACAM5 (Tusamitamab Biosimilar) antibody (ABIN7538086) specifically detects CEACAM5 (Tusamitamab Biosimilar) in ELISA and WB.
The antibody is reactive with Human samples.
Research Grade
Reactivity: Human
Host: Chimeric
Chimeric
unconjugated
Recombinant Antibody
Restrictions
For Research Use only
Buffer
PBS buffer PH7.5
Storage
-80 °C
Storage Comment
store at -80°C
Target
CEACAM5 (Tusamitamab Biosimilar)
Target Type
Biosimilar
Background
Tusamitamab is an IgG1 monoclonal antibody that targets CEACAM5. Tusamitamab can be used to synthesize Tusamitamab ravtansine, which is a first-in-class humanized antibody-drug conjugate (ADC) that combines Tusamitamab and DM4 (a potent maytansine derivative).